Related Experiment Video
Updated: Sep 1, 2025

Preparation of a Non-Cardiomyocyte Cell Suspension for Single-Cell RNA Sequencing from a Post-Myocardial Infarction Adult Mouse Heart
Published on: February 3, 2023
Identification of hub biomarkers of myocardial infarction by single-cell sequencing, bioinformatics, and machine
Qunhui Zhang1,2, Yang Guo1,2, Benyin Zhang2
1Research Center for High Altitude Medicine, Key Laboratory of High-Altitude Medicine (Ministry of Education), Key Laboratory of Application and Foundation for High Altitude Medicine Research in Qinghai Province (Qinghai-Utah Joint Research Key Lab for High Altitude Medicine), Qinghai University, Xining, China.
Background:
Myocardial infarction (MI) is one of the first cardiovascular diseases endangering human health. Inflammatory response plays a significant role in the pathophysiological process of MI. Messenger RNA (mRNA) has been proven to play a key role in cardiovascular diseases. Single-cell sequencing (SCS) technology is a new technology for high-throughput sequencing analysis of genome, transcriptome, and epigenome at the single-cell level, and it also plays an important role in the diagnosis and treatment of cardiovascular diseases. Machine learning algorithms have a wide scope of utilization in biomedicine and have demonstrated superior efficiency in clinical trials. However, few studies integrate these three methods to investigate the role of mRNA in MI. The aim of this study was to screen the expression of mRNA, investigate the function of mRNA, and provide an underlying scientific basis for the diagnosis of MI.
Methods:
In total, four RNA microarray datasets of MI, namely, GSE66360, GSE97320, GSE60993, and GSE48060, were downloaded from the Gene Expression Omnibus database. The function analysis was carried out by Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Disease Ontology (DO) enrichment analysis. At the same time, inflammation-related genes (IRGs) were acquired from the GeneCards database. Then, 52 co-DEGs were acquired from differentially expressed genes (DEGs) in differential analysis, IRGs, and genes from SCS, and they were used to construct a protein-protein interaction (PPI) network. Two machine learning algorithms, namely, (1) least absolute shrinkage and selection operator and (2) support vector machine recursive feature elimination, were used to filter the co-DEGs. Gene set enrichment analysis (GSEA) was performed to screen the hub-modulating signaling pathways associated with the hub genes. The results were validated in GSE97320, GSE60993, and GSE48060 datasets. The CIBERSORT algorithm was used to analyze 22 infiltrating immune cells in the MI and healthy control (CON) groups and to analyze the correlation between these immune cells. The Pymol software was used for molecular docking of hub DEGs and for potential treatment of MI drugs acquired from the COREMINE.
Results:
A total of 126 DEGs were in the MI and CON groups. After screening two machine learning algorithms and key co-DEGs from a PPI network, two hub DEGs (i.e., IL1B and TLR2) were obtained. The diagnostic efficiency of IL1B, TLR2, and IL1B + TLR2 showed good discrimination in the four cohorts. GSEA showed that KEGG enriched by DEGs were mainly related to inflammation-mediated signaling pathways, and GO biological processes enriched by DEGs were linked to biological effects of various inflammatory cells. Immune analysis indicated that IL1B and TLR2 were correlated with various immune cells. Dan shen, san qi, feng mi, yuan can e, can sha, san qi ye, san qi hua, and cha shu gen were identified as the potential traditional Chinese medicine (TCM) for the treatment of MI. 7-hydroxyflavone (HF) had stable combinations with IL1B and TLR2, respectively.
Conclusion:
This study identified two hub DEGs (IL1B and TLR2) and illustrated its potential role in the diagnosis of MI to enhance our knowledge of the underlying molecular mechanism. Infiltrating immune cells played an important role in MI. TCM, especially HF, was a potential drug for the treatment of MI.
Insights
This study identified IL1B and TLR2 as key messenger RNA (mRNA) biomarkers for myocardial infarction (MI) diagnosis. These findings highlight the role of immune cells and potential traditional Chinese medicine treatments for MI.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Bioinformatics
Background:
- Myocardial infarction (MI) involves significant inflammatory responses and messenger RNA (mRNA) dysregulation.
- Single-cell sequencing (SCS) and machine learning offer novel approaches to study complex diseases like MI.
- Integrating these technologies can reveal crucial molecular mechanisms in cardiovascular diseases.
Purpose of the Study:
- To screen and identify key mRNA expression patterns in myocardial infarction.
- To investigate the functional roles of identified mRNAs in the pathophysiology of MI.
- To provide a scientific basis for improved MI diagnosis and potential therapeutic strategies.
Main Methods:
- Analysis of four myocardial infarction (MI) RNA microarray datasets (GSE66360, GSE97320, GSE60993, GSE48060).
- Utilized Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Disease Ontology (DO) for functional enrichment analysis.
- Employed machine learning algorithms (LASSO, SVM-RFE) and protein-protein interaction (PPI) network construction to identify hub genes.
- Immune cell infiltration analysis using CIBERSORT and molecular docking for potential drug discovery.
Main Results:
- Identified 126 differentially expressed genes (DEGs) in MI, with IL1B and TLR2 selected as key hub DEGs.
- IL1B and TLR2 demonstrated significant diagnostic efficiency for MI across multiple cohorts.
- Enrichment analysis revealed pathways related to inflammation and immune cell functions.
- Correlations between IL1B, TLR2, and various immune cells were established.
Conclusions:
- IL1B and TLR2 are identified as crucial diagnostic biomarkers for myocardial infarction (MI).
- Infiltrating immune cells play a significant role in MI pathogenesis.
- Traditional Chinese Medicine (TCM), particularly 7-hydroxyflavone (HF), shows potential for MI treatment.

